Supply Chain

FDA Releases Long-Term National Strategy to Increase Resiliency of U.S. Infant Formula Market

The strategy builds on the Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market that was released in early 2023 in direct response to the February 2022 infant formula recall and the subsequent shortage of infant formula in the U.S.